FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| F. H. Investments. Inc. DBA Asteria Health | 067684453 | 79559-4210 | 79559-4210-1 | Testosterone; Anastrozole | 200 mg/210 mg; 10 mg/210 mg | 2025-1 | valid | 2026-10-06 | |
| F. H. Investments. Inc. DBA Asteria Health | 79559-4210 | 79559-4210-1 | S-TA210 | S-TA210 | 200 mg/210 mg; 10 mg/210 mg | 2025-1 | valid | 2026-09-18 | |
| F. H. Investments. Inc. DBA Asteria Health | 067684453 | 79559-4210 | 79559-4210-1 | Testosterone; Anastrozole | 200 mg/210 mg; 10 mg/210 mg | 2024-2 | valid | 2026-10-06 | |
| F. H. Investments. Inc. DBA Asteria Health | 79559-4210 | 79559-4210-1 | S-TA210 | S-TA210 | 200 mg/210 mg; 10 mg/210 mg | 2024-2 | valid | 2026-09-18 | |
| F. H. Investments. Inc. DBA Asteria Health | 067684453 | 79559-4210 | 79559-4210-1 | Testosterone; Anastrozole | 200 mg/210 mg; 10 mg/210 mg | 2023-2 | valid | 2026-10-06 | |
| F. H. Investments. Inc. DBA Asteria Health | 067684453 | 79559-4210 | 79559-4210-1 | Testosterone; Anastrozole | 200 mg/210 mg; 10 mg/210 mg | 2022-2 | valid | 2026-10-06 |